Clinical trials
Observational Nephritis, Hereditary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
| 2012 | 3 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Minnesota | 4 |
| Alport Syndrome Foundation | 1 |
| CENTOGENE GmbH Rostock | 1 |
| Centre Hospitalier Universitaire de Liege | 1 |
| Genzyme, a Sanofi Company | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Nanjing University School of Medicine | 1 |
| Novartis Pharmaceuticals | 1 |
| RTI International | 1 |
| Stefan Lujinschi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nephritis, Hereditary | 16 |
| Kidney Diseases | 4 |
| Cystinosis | 3 |
| Pseudohypoaldosteronism | 3 |
| Anemia, Sickle Cell | 2 |
| Argininosuccinic Aciduria | 2 |
| Biotinidase Deficiency | 2 |
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 2 |
| Citrullinemia | 2 |
| Congenital Hyperinsulinism | 2 |
Trials
Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.